Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Women's Health and Genetics/Laboratory Corporation of America, |
RCV001732820 | SCV001983519 | uncertain significance | not specified | 2021-09-25 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV003470882 | SCV004206830 | uncertain significance | Isolated focal cortical dysplasia type II | 2023-09-26 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004681236 | SCV005180975 | uncertain significance | Hereditary cancer-predisposing syndrome | 2024-06-21 | criteria provided, single submitter | clinical testing | The p.H401P variant (also known as c.1202A>C), located in coding exon 11 of the TSC2 gene, results from an A to C substitution at nucleotide position 1202. The histidine at codon 401 is replaced by proline, an amino acid with similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the available evidence, the clinical significance of this variant remains unclear. |
Labcorp Genetics |
RCV005057556 | SCV005700576 | uncertain significance | Tuberous sclerosis 2 | 2024-03-27 | criteria provided, single submitter | clinical testing | This sequence change replaces histidine, which is basic and polar, with proline, which is neutral and non-polar, at codon 401 of the TSC2 protein (p.His401Pro). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with TSC2-related conditions. ClinVar contains an entry for this variant (Variation ID: 1301335). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt TSC2 protein function with a negative predictive value of 95%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |